Your browser doesn't support javascript.
loading
Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition.
Gaikwad, Archana Vijay; Lu, Wenying; Dey, Surajit; Bhattarai, Prem; Chia, Collin; Larby, Josie; Haug, Greg; Myers, Stephen; Jaffar, Jade; Westall, Glen; Singhera, Gurpreet Kaur; Hackett, Tillie-Louise; Markos, James; Eapen, Mathew Suji; Sohal, Sukhwinder Singh.
Affiliation
  • Gaikwad AV; Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
  • Lu W; National Health and Medical Research Council (NHMRC) Centre of Research Excellence (CRE) in Pulmonary Fibrosis, Respiratory Medicine and Sleep Unit, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
  • Dey S; Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
  • Bhattarai P; National Health and Medical Research Council (NHMRC) Centre of Research Excellence (CRE) in Pulmonary Fibrosis, Respiratory Medicine and Sleep Unit, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
  • Chia C; Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
  • Larby J; Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
  • Haug G; Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
  • Myers S; Dept of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, Australia.
  • Jaffar J; Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
  • Westall G; Dept of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, Australia.
  • Singhera GK; Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
  • Hackett TL; Dept of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, Australia.
  • Markos J; Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
  • Eapen MS; Dept of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, VIC, Australia.
  • Sohal SS; Dept of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.
ERJ Open Res ; 8(1)2022 Jan.
Article de En | MEDLINE | ID: mdl-35350273
ABSTRACT

Background:

Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible fibrotic interstitial lung disease. We performed size-based quantitation of pulmonary arterial remodelling in IPF and examined the role of endothelial-to-mesenchymal transition (EndMT) and effects on lung physiology.

Methods:

Resected lung tissues from 11 normal controls (NCs), and 13 IPF patients were differentially stained using the Movat Pentachrome technique. Size-based classification for pulmonary arteries was conducted in NC and IPF tissues. For each pulmonary artery, arterial size, luminal diameter, thickness of the intima, media and adventitia, and elastin deposition were quantified using Image ProPlus7.0 software. In addition, immunohistochemical staining was performed for EndMT markers and collagen.

Results:

Large and medium-size arterial numbers were significantly reduced in IPF compared to NCs (p<0.0001). Intima thickness was highest in the arterial range of 200-399 µm and 600-1000 µm (p<0.0001), while medial and adventitial thickness was significant across 200-1000 µm (p<0.05) compared to NC. Medial thickness was found to significantly affect the diffusing capacity of the lungs for carbon monoxide (D LCO) (r=-0.8, p=0.01). Total arterial elastin in IPF was higher across all arterial ranges except 100-199 µm in IPF than in NC, with the greatest differences in 200-399 µm (p<0.001) and 600-1000 µm (p<0.001). Total elastin also negatively correlated with D LCO (r'=-0.63, p=0.04) in IPF. An increase in EndMT markers and collagen type I/ IV was observed.

Conclusions:

This is the first study demonstrating size-based differences in pulmonary arteries in IPF and its detrimental effect on lung physiology. The process of EndMT might be central to these vascular remodelling changes and could be a potential novel therapeutic target.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: ERJ Open Res Année: 2022 Type de document: Article Pays d'affiliation: Australie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: ERJ Open Res Année: 2022 Type de document: Article Pays d'affiliation: Australie